Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions
- PMID: 20852595
- DOI: 10.1038/modpathol.2010.180
Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions
Abstract
The inherent longetivity of stem cells causes them to be susceptible to multiple genetic hits. Thus, it is not surprising that stem cells are implicated in the etiopathogenesis of select cutaneous neoplasms. However, most studies to date are restricted to the use of a single marker (p63, cytokeratin-15 or cytokeratin-19) and do not appear to compare distribution of stem cell markers in a spectrum of cutaneous in situ versus invasive epithelial malignancies. In this study, we evaluate expression of cytokeratin-15, cytokeratin-19, and p63 in a series of primary cutaneous epithelial lesions that include actinic keratosis (n=29), squamous cell carcinoma in situ (n=30), bowenoid papulosis (n=15) and squamous cell carcinoma, well differentiated (n=29) in order to evaluate the role of stem cell marker expression in the grading and development of in situ and invasive malignancies. For cytokeratin-15, expression was retained in actinic keratosis (38%), squamous cell carcinoma in situ (53%) and bowenoid papulosis (60%) but appeared to be lost in squamous cell carcinoma (3%) with statistically significant differences observed between groups that retained versus those that did not (P<0.05 for all three); for cytokeratin-19, patchy yet basal expression was noted in actinic keratosis (21%), patchy and suprabasal expression was noted in squamous cell carcinoma in situ (37%), bowenoid papulosis (13%) and squamous cell carcinoma (24%) with no statistically significant differences between groups; for p63, expression was retained in actinic keratosis (90%), squamous cell carcinoma in situ (87%), bowenoid papulosis (60%) and squamous cell carcinoma (100%) with no statistically significant differences between groups. In summary, our findings expand the neoplasms which involve stem cells to include cutaneous epithelial malignancies. Differential localization of each of these markers argues in favor of stem cell heterogeneity.
Similar articles
-
Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.Ann Diagn Pathol. 2016 Feb;20:1-6. doi: 10.1016/j.anndiagpath.2015.11.001. Epub 2015 Nov 10. Ann Diagn Pathol. 2016. PMID: 26740287
-
Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.Int J Dermatol. 2010 Jan;49(1):48-52. doi: 10.1111/j.1365-4632.2009.04191.x. Int J Dermatol. 2010. PMID: 20465611
-
[Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].Pathologe. 2015 Feb;36(1):16-29. doi: 10.1007/s00292-014-2063-3. Pathologe. 2015. PMID: 25663185 Review. German.
-
Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.Br J Dermatol. 2005 Dec;153(6):1166-75. doi: 10.1111/j.1365-2133.2005.06898.x. Br J Dermatol. 2005. PMID: 16307653
-
Bowenoid papulosis: a review.Cutis. 1981;27(1):92-8. Cutis. 1981. PMID: 7009074 Review.
Cited by
-
Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancer.Oncol Lett. 2023 Aug 30;26(4):447. doi: 10.3892/ol.2023.14034. eCollection 2023 Oct. Oncol Lett. 2023. PMID: 37720670 Free PMC article.
-
Molecular hydrogen promotes wound healing by inducing early epidermal stem cell proliferation and extracellular matrix deposition.Inflamm Regen. 2023 Mar 28;43(1):22. doi: 10.1186/s41232-023-00271-9. Inflamm Regen. 2023. PMID: 36973725 Free PMC article.
-
Working formulation of neuroendocrine tumors of the skin and breast.Endocr Pathol. 2014 Jun;25(2):141-50. doi: 10.1007/s12022-014-9319-6. Endocr Pathol. 2014. PMID: 24729037 Review.
-
Microscopy-guided laser ablation for the creation of complex skin models with folliculoid appendages.Bioeng Transl Med. 2020 Dec 15;6(2):e10195. doi: 10.1002/btm2.10195. eCollection 2021 May. Bioeng Transl Med. 2020. PMID: 34027085 Free PMC article.
-
Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.Dermatopathology (Basel). 2015 Apr 8;2(1):15-42. doi: 10.1159/000377698. eCollection 2015 Jan-Mar. Dermatopathology (Basel). 2015. PMID: 27047932 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous